Soligenix

SNGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.534 M

$0.39 +3.51%

Close of 7 Aug 2026

Revenue

$119.4K

#3607 by revenue

Earnings

-$11.1M

Loss-making

Shares outstanding

21,765,479

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#436ExicureXCUR$8.57M
#437Processa PharmaceuticalsPCSA$8.55M
#438SoligenixSNGX$8.53M
#439Adial PharmaceuticalsADIL$8.53M
#440ImmuronIMRN$8.32M

Where these numbers come from

Share counts and financials for Soligenix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.